SA
BFRI icon

Sanctuary Advisors’s Biofrontera BFRI Stock Holding History

Sanctuary Advisors’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.25K Buy
10,200
+100
+1% +$86 ﹤0.01% 2524
2025
Q4 		$5.76K Buy
+10,100
New +$9.13K ﹤0.01% 2409

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sanctuary Advisors's BFRI Position: Q1 2026 in Review

Sanctuary Advisors increased its Biofrontera (BFRI) stake by 0.99% in Q1 2026, buying an estimated $86 and bringing the position to 10,200 shares worth $8.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2524.

Sanctuary Advisors first reported a position in BFRI in Q4 2025 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • Sanctuary Advisors held 10,200 shares of Biofrontera worth $8.25K as of Q1 2026.
  • Sanctuary Advisors bought 100 Biofrontera shares in Q1 2026, an estimated $86.
  • Biofrontera made up ﹤0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #2524 holding.
  • Sanctuary Advisors first reported a position in Biofrontera in Q4 2025 and has held it in 2 quarters since.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.